(MedPage Today) -- Patients with binge eating disorder showed a significant decrease in bingeing episodes while taking lisdexamfetamine dimesylate (Vyvanse) compared with placebo in two identical phase III trials, the drug's manufacturer said. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment